StockNews.com Initiates Coverage on Jounce Therapeutics (NAS

StockNews.com assumed coverage on shares of Jounce Therapeutics (NASDAQ:JNCE – Get Rating) in a research note issued to investors on Wednesday. The brokerage issued a hold rating on the stock. A number of other analysts have also issued reports on JNCE. Sumitomo Mitsui Financial Group reissued a neutral rating on shares of Jounce Therapeutics in […]

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , United States , Blackrock , United Kingdom General , America , Raymond James , Jamesp Allison , Padmanee Sharma , Louism Weiner , Piper Sandler , Kevinc Tang , Thomasf Gajewski , Robert Schreiber , Jounce Therapeutics Company Profile , Millennium Management , Jounce Therapeutics Inc , Blackrock Inc , Health Sciences , Sumitomo Mitsui Financial Group , America Corp , Securities Exchange Commission , Jounce Therapeutics , Get Rating , Mitsui Financial Group , Exchange Commission , Director Richard , Jounce Therapeutics Daily , Nasdaq Jnce , Jnce , Medical , Initiated Coverage , Stocknews Com ,